Showing results (11-20 of 6,950) with videos related to
Sort By:
Pageof 695
Journal of Clinical Pharmacology|April 18, 2001
Prevention of a first myocardial infarctionT D DayspringJournal of Clinical Pharmacology|April 18, 2001
Metabolic disposition and pharmacokinetics of [14C]-amprenavir, a human immunodeficiency virus type 1 (HIV-1) protease inhibitor, administered as a single oral dose to healthy male subjectsB M Sadler, G E Chittick, R E Polk, et al.Journal of Clinical Pharmacology|April 18, 2001
Effect of alosetron on the pharmacokinetics of alprazolamD L D'Souza, L M Levasseur, J Nezamis, et al.Journal of Clinical Pharmacology|April 18, 2001
Effect of alosetron on the pharmacokinetics of fluoxetineD L D'Souza, D C Dimmitt, D K Robbins, et al.Journal of Clinical Pharmacology|April 18, 2001
Decrease of intracranial pressure and weight with digoxin in obesityJ HannerzJournal of Clinical Pharmacology|November 5, 2002
Plasminogen activator inhibitor-1: physiologic role, regulation, and the influence of common pharmacologic agentsJames P Tsikouris, Jose A Suarez, Gary E MeyerroseJournal of Clinical Pharmacology|November 5, 2002
Bioequivalence testing for locally acting gastrointestinal products: what role for gamma scintigraphy?Ian WildingJournal of Clinical Pharmacology|November 5, 2002
Pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with bone metastasesTianling Chen, James Berenson, Robert Vescio, et al.Journal of Clinical Pharmacology|November 5, 2002
Sequential first-pass metabolism of nortilidine: the active metabolite of the synthetic opioid drug tilidineJacek Piotr Hajda, Eberhard Jähnchen, Svein Oie, et al.Journal of Clinical Pharmacology|November 5, 2002
Cannabidiol: an overview of some pharmacological aspectsRaphael Mechoulam, Linda A Parker, Ruth GallilyPageof 695